Glenmark – Recall of ranitidine
December 17, 2019 - The FDA announced a voluntary, consumer-level recall of prescription ranitidine due to potential N-nitrosodimethylamine (NDMA) amounts above levels established by the FDA, based on FDA-validated tests.
Download PDF
